sotalol has been researched along with atenolol in 108 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (43.52) | 18.7374 |
1990's | 22 (20.37) | 18.2507 |
2000's | 16 (14.81) | 29.6817 |
2010's | 16 (14.81) | 24.3611 |
2020's | 7 (6.48) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Baker, JG | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Andressen, KW; Brudeli, B; Klaveness, J; Levy, FO; Moltzau, LR; Nilsen, NO | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
Bischoff-Kont, I; Chaikuad, A; Faudone, G; Fürst, R; Heering, J; Kaiser, A; Knapp, S; Merk, D; Rachor, L; Willems, S; Zhubi, R | 1 |
Brown, HC; Carruthers, SG; McDevitt, DG; Shanks, RG | 1 |
Day, MD; Roach, AG | 1 |
Kiechel, JR; Meier, J | 1 |
Bellucci, R; Bonomi, L; Massa, F; Noya, E; Perfetti, S | 1 |
Jefferson, D; Jenner, P; Marsden, CD | 1 |
Allavena, A; Brambilla, G; Gazzaniga, GM; Martelli, A; Mazzei, M; Robbiano, L | 1 |
Gitter, S; Gordon, I; Rehavi, M; Speiser, Z | 1 |
Leloux, MS; Niessen, WM; van der Hoeven, RA | 1 |
Chan, L; Duffy, P; Urech, R | 1 |
Funck-Brentano, C; Roden, DM; Silberstein, DJ; Wood, AJ; Woosley, RL | 1 |
Bandyopadhyay, S; Klaunig, JE; Somani, P | 1 |
Alexopoulos, D; Cobbe, PC; Cobbe, SM; Johnston, J; McCaie, CP; Winner, SJ | 1 |
Ewy, GA; Freund, BJ; Hartzell, AA; Jilka, SM; Joyner, MJ; Morton, AR; Stanforth, PR; Wilmore, JH | 1 |
Ban, T; Fujita, T; Sada, H; Sada, S; Takahashi, Y | 1 |
Cruickshank, JM; Taylor, PJ | 2 |
Carrageta, MO; Raftery, EB | 1 |
Chiba, S; Kobayashi, M; Shimotori, M | 1 |
Fink, M; Lemmer, B; Ohm, T; Winkler, H | 1 |
Timmermans, PB; van Zwieten, PA | 1 |
Brownlee, WC; Durrington, PN; Large, DM | 1 |
Arendt, RM; Greenblatt, DJ; Mutschler, E; Ochs, HR; Schäfer-Korting, M | 1 |
Fishbein, L; Jackson, CD | 1 |
Abila, B; Marshall, RW; Richens, A; Wilson, JF | 1 |
Alexopoulos, D; Cobbe, SM; Manley, BS; Robinson, GJ | 1 |
Mwongera, FM; Raman, GV; Warren, DJ | 1 |
Desager, JP; Harvengt, C; Heller, F; Hulhoven, R | 1 |
Komar, K; Tarnow, J | 1 |
Cobbe, SM; Forfar, JC; Way, BP | 1 |
Cobbe, SM; Manley, BS | 1 |
Campbell, DG; Heyma, P; Larkins, RG | 1 |
Jounela, AJ; Juustila, H; Lilja, M; Mattila, MJ | 1 |
Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
Dean, S; Jack, DB; Kendall, MJ; Laugher, S | 1 |
Jefferson, D; Leigh, PN; Marsden, CD; Twomey, A | 2 |
Laakso, M; Neuvonen, PJ; Pentikäinen, PJ; Pyörälä, K | 1 |
Kudo, Y; Sokabe, H; Zehr, JE | 1 |
Cocco, F; Dessì Fulgheri, P; Dettori, S; Fiori, C; Glorioso, N; Madeddu, P; Rappelli, A; Sanna, G | 1 |
Gerber, JG; Nies, AS; Olson, RD | 1 |
Gerstenbrand, F; Klingler, D; Poewe, W | 1 |
Christensen, LK; Hansen, JM; Perrild, H; Skovsted, L | 1 |
Lucchesi, BR; Patterson, E | 1 |
Friedewald, WT; Frishman, WH; Furberg, CD | 1 |
Arnold, JM; McDevitt, DG | 1 |
Abed, J; Donaldson, R; Nashat, F; Taggart, P | 1 |
Day, NH; Parr, GD | 1 |
Schoeman, HS; Sommers, DK; van Wyk, M | 1 |
Kärkkäinen, S | 1 |
Asmal, AC; Brayshaw, P; Leary, WP; Williams, P | 1 |
Aärynen, M; Hämeenaho, P; Mäkelä, M; Mattila, MJ | 1 |
Balnave, K; Harron, DW; Kinney, CD; Russell, CJ; Shanks, RG; Wilson, R | 1 |
De Clerck, F; Lu, HR; Remeysen, P | 1 |
Doggrell, SA | 1 |
Raza, A | 1 |
Pearce, SH; Rees, CJ; Smith, RH | 1 |
Barbey, JT; Funck-Brentano, C; Wellstein, A; Woosley, RL; Yasuda, SU | 1 |
Fiset, C; Gilbert, M; Philippon, F; Turgeon, J | 1 |
Johnson, MD; Morton, KD; Van de Kar, LD | 1 |
Buckley, NA; Dawson, AH; Epid, D; Reith, DM; Sayer, GP; Whyte, IM | 1 |
Calders, P; Kint, J; Matthys, D; Pannier, JL | 1 |
Läer, S; Neumann, J; Scholz, H; Uebeler, P; Zimmermann, N | 1 |
Kim, KJ; Lee, VH; Mathias, NR | 1 |
Chaudron, JM; de Meester, A; de Roy, L | 1 |
Alessandrini, RS; Goldberger, JJ; Kadish, AH; Kane, BJ; McPherson, DD | 1 |
Birchall, AS; Channer, KS; Smith, M; Steeds, RP | 1 |
O'Brien, E; Owens, P | 1 |
Akerman, S; Järvinen, K; Karhu, M; Paronen, P; Savolainen, J; Svarfvar, B; Tarvainen, T | 1 |
Juhela, P; Kaartinen, M; Kähkönen, S | 1 |
Atkins, CE; DeFrancesco, TC; Gordon, SG; Hamlin, RL; Keene, BW; Meurs, KM; Miller, MW; Moise, NS; Spier, AW; Wright, NA | 1 |
Blasco, M; Carbonell, N; Jordá, A; Martínez-León, J; Núñez, J; Otero, E; Sanjuán, R | 1 |
Botterhuis, N; Hermans, JJ; Janssen, BJ; Maessen, JG; Smits, JF; van Brakel, TJ; van Essen, H | 1 |
Anthonsen, HS; Ho, TS; Pedersen-Bjergaard, S; Rasmussen, KE; Reubsaet, JL | 1 |
Auler, JO; Carmona, MJ; Leite, Fda S; Omosako, CE; Pereira, VA; Santos, SR | 1 |
Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
Alder, AC; Escher, BI; Maurer, M; Richle, P; Schaffner, C | 1 |
Abildstrøm, SZ; Andersen, SS; Folke, F; Fosbøl, E; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Rasmussen, S; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
Galceran, MT; Huerta-Fontela, M; Ventura, F | 1 |
Furutani, K; Inanobe, A; Kurachi, Y; Ohno, Y; Yamakawa, Y | 1 |
Antony Muthu Prabhu, A; Rajendiran, N; Subramanian, VK | 1 |
Crijns, HJ; Olshansky, B; Rienstra, M; Van Gelder, IC | 1 |
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
Chen, YW; Hsu, CW; Huang, KY; Lin, CH; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC | 1 |
LeBlanc, NL; Owens, EJ; Scollan, KF; Treseder, J | 1 |
Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
Sun, H; Wang, Y; Xu, J; Zhang, W | 1 |
Obernberger, C; Shear, M; Showers, A; Tjostheim, SS | 1 |
8 review(s) available for sotalol and atenolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
Hypertension and beta-blockers. Are they all the same?
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Labetalol; Metoprolol; Pindolol; Receptors, Adrenergic, alpha; Sotalol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Rate control in atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Calcium Channel Blockers; Cardiac Resynchronization Therapy; Catheter Ablation; Digoxin; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Pacemaker, Artificial; Patient-Centered Care; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Sotalol | 2016 |
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Celiprolol; Disease Progression; Female; Humans; Incidence; Infusions, Intravenous; Male; Practolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Sotalol; Status Asthmaticus; Timolol | 2021 |
22 trial(s) available for sotalol and atenolol
Article | Year |
---|---|
beta-Adrenoreceptor antagonists in essential tremor.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Propanolamines; Propranolol; Pulse; Sotalol; Tremor | 1979 |
A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism.
Topics: Adult; Atenolol; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Propranolol; Random Allocation; Receptors, Adrenergic, beta; Sotalol; Stereoisomerism | 1990 |
A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atenolol; Cardiac Complexes, Premature; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Monitoring, Physiologic; Myocardial Infarction; Random Allocation; Sotalol | 1988 |
Alterations in plasma lipids consequent to endurance training and beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Coronary Disease; Humans; Lipids; Male; Physical Education and Training; Physical Endurance; Sotalol | 1989 |
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cholesterol; Cholesterol, HDL; Female; Half-Life; Heart Rate; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, VLDL; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Sotalol; Triglycerides | 1985 |
Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man?
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Hand; Heart Rate; Humans; Male; Physical Exertion; Propranolol; Receptors, Adrenergic, beta; Sotalol; Tremor | 1986 |
Comparison of the effects of atenolol, sotalol and labetalol on muscle blood flow in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Humans; Labetalol; Male; Muscles; Physical Exertion; Regional Blood Flow; Sotalol | 1986 |
Comparison of the effects of chronic oral therapy with atenolol and sotalol on ventricular monophasic action potential duration and effective refractory period.
Topics: Action Potentials; Administration, Oral; Aged; Atenolol; Clinical Trials as Topic; Coronary Disease; Female; Heart; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Random Allocation; Refractory Period, Electrophysiological; Sotalol; Time Factors | 1988 |
Interaction of clonidine and beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Atenolol; Blood Pressure; Clinical Trials as Topic; Clonidine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Rabbits; Sotalol | 1980 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
beta-Adrenoceptor antagonists and essential tremor.
Topics: Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Random Allocation; Sotalol; Tremor | 1981 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol.
Topics: Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Pulse; Receptors, Adrenergic, beta; Sotalol; Tremor | 1983 |
The effects of two combinations of a beta-blocker and a diuretic on diuresis in normal subjects.
Topics: Adult; Atenolol; Chlorthalidone; Clinical Trials as Topic; Diuresis; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Male; Potassium; Sodium; Sotalol; Uric Acid; Urine | 1984 |
Antihypertensive effects of sotalol and atenolol given once daily.
Topics: Adult; Aged; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Male; Middle Aged; Propanolamines; Pulse; Sotalol | 1980 |
Prazosin enhances the antihypertensive effects of beta-blockers during isometric and dynamic exercise.
Topics: Adult; Atenolol; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Prazosin; Propanolamines; Quinazolines; Sotalol | 1981 |
Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
Topics: Adolescent; Adult; Atenolol; Dose-Response Relationship, Drug; Half-Life; Heart Rate; Humans; Male; Metoprolol; Physical Exertion; Propanolamines; Sotalol; Time Factors | 1981 |
d-sotalol reduces heart rate in vivo through a beta-adrenergic receptor-independent mechanism.
Topics: Adult; Analysis of Variance; Atenolol; Double-Blind Method; Exercise; Female; Heart Rate; Humans; Male; Receptors, Adrenergic, beta; Sotalol; Stereoisomerism | 1993 |
An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Atrial Fibrillation; Cross-Over Studies; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Humans; Male; Prospective Studies; Sotalol | 1999 |
Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Dog Diseases; Dogs; Drug Therapy, Combination; Heart Rate; Mexiletine; Procainamide; Random Allocation; Sotalol; Syncope; Treatment Outcome; Ventricular Premature Complexes | 2002 |
Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Male; Postoperative Complications; Regression Analysis; Sotalol | 2004 |
Echocardiographic and electrocardiographic effects of atenolol versus sotalol in dogs with severe subaortic stenosis.
Topics: Animals; Anti-Arrhythmia Agents; Aortic Stenosis, Subvalvular; Atenolol; Constriction, Pathologic; Cross-Over Studies; Dog Diseases; Dogs; Echocardiography; Electrocardiography; Pilot Projects; Prospective Studies; Sotalol | 2022 |
79 other study(ies) available for sotalol and atenolol
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
Topics: Administration, Oral; Animals; Biphenyl Compounds; Caco-2 Cells; Cell Line; Cell Survival; Guinea Pigs; Half-Life; HEK293 Cells; Humans; Male; Mice; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT4; Recombinant Proteins; Serotonin 5-HT4 Receptor Agonists | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; HEK293 Cells; Humans; Molecular Structure; Orphan Nuclear Receptors; Propranolol; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship | 2021 |
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Dose-Response Relationship, Drug; Drug Interactions; Heart Rate; Humans; Male; Oxprenolol; Physical Exertion; Practolol; Propranolol; Sotalol; Sympathomimetics; Time Factors | 1977 |
The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Blood Pressure; Brain; Cats; Female; Heart Rate; Injections, Intraventricular; Male; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol | 1975 |
Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Drug Tolerance; Ethanolamines; Intraocular Pressure; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rabbits; Sotalol; Timolol | 1979 |
Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cell Survival; DNA; DNA Damage; DNA Repair; Humans; Liver; Male; Metoprolol; Nadolol; Nitrosamines; Nitrosation; Oxprenolol; Propranolol; Rats; Rats, Inbred Strains; Sodium Nitrite; Sotalol | 1991 |
Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Avoidance Learning; Birth Weight; Body Weight; Brain; Female; Gestational Age; Heart Rate; Male; Motor Activity; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Sotalol | 1991 |
Thermospray liquid chromatography/mass spectrometry of polar beta-blocking drugs: preliminary results.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Labetalol; Sotalol | 1991 |
High-performance liquid chromatographic assay of sotalol: improved procedure and investigation of peak broadening.
Topics: Alcohols; Atenolol; Chromatography, High Pressure Liquid; Humans; Reference Standards; Solvents; Sotalol; Spectrophotometry, Ultraviolet | 1990 |
Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
Topics: Amiodarone; Animals; Atenolol; Biomarkers; Cardiotonic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Liver; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Procainamide; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Verapamil | 1990 |
Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Guinea Pigs; In Vitro Techniques; Ion Channels; Methylation; Myocardial Contraction; Papillary Muscles; Propanolamines; Sotalol; Structure-Activity Relationship | 1985 |
Distribution coefficients of atenolol and sotalol.
Topics: Atenolol; Hydrogen-Ion Concentration; Solubility; Sotalol | 1985 |
Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Carteolol; Dogs; In Vitro Techniques; Oxprenolol; Propranolol; Sinoatrial Node; Sotalol | 1985 |
Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Half-Life; Heart Rate; Kinetics; Male; Metoprolol; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Structure-Activity Relationship; Time Factors; Tissue Distribution | 1985 |
Brain levels and acute antihypertensive activity of beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Brain Chemistry; Cats; Heart Rate; Infusions, Intra-Arterial; Injections, Intravenous; Metoprolol; Sotalol; Time Factors; Tissue Distribution | 1985 |
Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Half-Life; Humans; Kinetics; Lipids; Male; Metoprolol; Propranolol; Solubility; Sotalol | 1985 |
Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Isomerism; Metoprolol; Muscle Contraction; Nadolol; Oxprenolol; Papillary Muscles; Rabbits; Refractory Period, Electrophysiological; Sotalol | 1986 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, LDL; Oxprenolol; Penbutolol; Pindolol; Sotalol | 1987 |
Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bupranolol; Dobutamine; Hemodynamics; Humans; Metoprolol; Middle Aged; Myocardial Revascularization; Premedication; Sotalol | 1988 |
Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atenolol; Dose-Response Relationship, Drug; Extracellular Space; Isoproterenol; Membrane Potentials; Neural Conduction; Papillary Muscles; Potassium; Rabbits; Sotalol | 1985 |
Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cyclic AMP; Epinephrine; In Vitro Techniques; Isoproterenol; Kidney Tubules; Propranolol; Rats; Sotalol; Thyroxine; Triiodothyronine | 1980 |
Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: II. A further five beta blockers and dihydralazine.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Chromatography, Thin Layer; Dihydralazine; Humans; Hypertension; Labetalol; Sotalol | 1980 |
Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrocardiography; Heart Ventricles; Humans; Kinetics; Male; Middle Aged; Sotalol; Syncope; Tachycardia; Ventricular Fibrillation | 1981 |
A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cardiovascular System; Female; Heart Rate; Isoproterenol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Sotalol | 1981 |
[Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Atenolol; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Metoprolol; Middle Aged; Prazosin; Renin; Sotalol; Spironolactone | 1981 |
Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.
Topics: Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Dogs; Female; Indomethacin; Isoproterenol; Kidney; Male; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin; Sotalol; Stimulation, Chemical | 1982 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol; Sotalol; Tremor | 1982 |
Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Humans; Hyperthyroidism; Metoprolol; Middle Aged; Propranolol; Sotalol; Triiodothyronine; Triiodothyronine, Reverse | 1983 |
Distribution coefficients of atenolol and sotalol.
Topics: Atenolol; Solubility; Sotalol | 1984 |
Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Dose-Response Relationship, Drug; Heart Conduction System; Male; Nadolol; Propanolamines; Propranolol; Sotalol; Ventricular Fibrillation | 1984 |
Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Female; Fingers; Heart Rate; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Isoproterenol; Male; Practolol; Propranolol; Sotalol; Tremor | 1984 |
Class III action of beta-blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Ventricles; Male; Nadolol; Oxprenolol; Pindolol; Propanolamines; Propranolol; Sotalol; Timolol | 1984 |
Distribution coefficients of atenolol and sotalol: a critique.
Topics: Atenolol; Humans; Kinetics; Sotalol | 1984 |
High-performance liquid chromatographic determination of sotalol in biological fluids.
Topics: Atenolol; Body Fluids; Chromatography, High Pressure Liquid; Drug Stability; Humans; Sotalol; Time Factors | 1984 |
Antifibrillary action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Chromans; Disease Models, Animal; Electric Stimulation; Electrocardiography; Encainide; Ethanolamines; Guinea Pigs; Heart; Heart Conduction System; Injections, Intravenous; Male; Metoprolol; Nebivolol; Phenethylamines; Piperidines; Sotalol; Sulfonamides; Ventricular Fibrillation; Verapamil | 1995 |
The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Ethanolamines; Heart; Heart Atria; In Vitro Techniques; Isoproterenol; Kinetics; Male; Molecular Structure; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Portal Vein; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Sotalol; Stereoisomerism | 1993 |
Beta-receptor blockade in preventing sudden death.
Topics: Adrenergic beta-Antagonists; Atenolol; Death, Sudden, Cardiac; Humans; Metoprolol; Practolol; Sotalol; Ventricular Fibrillation | 1993 |
Fetal monitoring during maternal antiarrhythmic therapy.
Topics: Adenosine; Adult; Atenolol; Cardiotocography; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Sotalol; Tachycardia, Supraventricular; Transposition of Great Vessels; Ultrasonography, Prenatal | 1993 |
Stereoselective high-performance liquid chromatographic assay for the determination of sotalol enantiomers in biological fluids.
Topics: Atenolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Reference Standards; Sotalol; Spectrometry, Fluorescence; Stereoisomerism | 1993 |
Serotonin and stress-induced increases in renin secretion are not blocked by sympathectomy/adrenal medullectomy but are blocked by beta antagonists.
Topics: Adrenal Medulla; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atenolol; Fenfluramine; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Renin; Serotonin; Sotalol; Stress, Physiological; Sympathectomy, Chemical | 1995 |
Relative toxicity of beta blockers in overdose.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child, Preschool; Databases, Factual; Drug Overdose; Female; Humans; Infant; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Prospective Studies; Seizures; Sotalol | 1996 |
Effects of acute cardioselective and non-selective beta-adrenergic blockade on plasma ammonia levels in exercising dogs.
Topics: Adrenergic beta-Antagonists; Ammonia; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Heart Rate; Infusions, Intravenous; Male; Physical Conditioning, Animal; Propranolol; Sotalol | 1996 |
Determination of sotalol in human cardiac tissue by high-performance liquid chromatography.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atenolol; Chromatography, High Pressure Liquid; Heart Atria; Heart Ventricles; Humans; Myocardium; Sensitivity and Specificity; Sotalol | 1996 |
Targeted drug delivery to the respiratory tract: solute permeability of air-interface cultured rabbit tracheal epithelial cell monolayers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Biological Transport; Cell Membrane Permeability; Cells, Cultured; Dextrans; Epithelium; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Male; Molecular Weight; Rabbits; Sotalol; Trachea | 1996 |
Usefulness of isoproterenol in the induction of clinical sustained ventricular tachycardia during electrophysiological study.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Pacing, Artificial; Electrocardiography; Female; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Sotalol; Syncope; Tachycardia, Ventricular | 1997 |
Cardiac memory: a mechanical and electrical phenomenon.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography; Electrocardiography; Equipment Design; Female; Heart; Humans; Male; Memory; Middle Aged; Models, Cardiovascular; Pacemaker, Artificial; Sotalol; Time Factors; Ventricular Function, Left; Warfarin | 1997 |
Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Ambulatory; Celiprolol; Chi-Square Distribution; Coronary Disease; Diastole; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Female; Humans; Hypotension; Iatrogenic Disease; Male; Metoprolol; Middle Aged; Myocardial Ischemia; Sotalol | 1999 |
Drug release from a porous ion-exchange membrane in vitro.
Topics: Acrylic Resins; Adsorption; Atenolol; Biocompatible Materials; Cations; Dexmedetomidine; Diazepam; Drug Delivery Systems; Hydrogen-Ion Concentration; Ion Transport; Kinetics; Membranes, Artificial; Polyvinyls; Propranolol; Sotalol; Surface Properties; Timolol | 1999 |
Permanent pacing-aid to carry out long-term lithium therapy in manic patient with symptomatic bradycardia.
Topics: Adrenergic beta-Antagonists; Aged; Antimanic Agents; Atenolol; Bipolar Disorder; Bradycardia; Glaucoma; Humans; Hypertension; Lithium; Male; Pacemaker, Artificial; Sotalol | 2000 |
Intrapericardial delivery enhances cardiac effects of sotalol and atenolol.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Body Weight; Drug Delivery Systems; Infusions, Intralesional; Infusions, Intravenous; Male; Myocardial Contraction; Pericardium; Rats; Rats, Wistar; Sotalol | 2004 |
Liquid-phase microextraction based on carrier mediated transport combined with liquid chromatography-mass spectrometry. New concept for the determination of polar drugs in a single drop of human plasma.
Topics: Amphetamine; Atenolol; Chemical Fractionation; Chromatography, Liquid; Cimetidine; Humans; Microchemistry; Morphine; Pharmaceutical Preparations; Phenylpropanolamine; Practolol; Sensitivity and Specificity; Solvents; Sotalol; Spectrometry, Mass, Electrospray Ionization | 2005 |
A micromethod for the quantification of atenolol in plasma using high-performance liquid chromatography with fluorescence detection: therapeutic drug monitoring of two patients with severe coronary insufficiency before cardiac surgery.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged, 80 and over; Angina, Unstable; Atenolol; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluorescence; Humans; Microchemistry; Middle Aged; Reproducibility of Results; Sotalol; Temperature; Time Factors | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Elimination of beta-blockers in sewage treatment plants.
Topics: Adrenergic beta-Antagonists; Adsorption; Atenolol; Chromatography, High Pressure Liquid; Kinetics; Metoprolol; Molecular Structure; Propranolol; Sotalol; Tandem Mass Spectrometry; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2007 |
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Female; Humans; Kaplan-Meier Estimate; Male; Metoprolol; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Recurrence; Registries; Sotalol | 2009 |
Occurrence and removal of pharmaceuticals and hormones through drinking water treatment.
Topics: Atenolol; Carbamazepine; Hormones; Hydrochlorothiazide; Ozone; Pharmaceutical Preparations; Phenytoin; Sotalol; Water Pollutants, Chemical; Water Purification; Water Supply | 2011 |
Pharmacophore modeling for hERG channel facilitation.
Topics: Animals; Atenolol; Chlorpheniramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoxetine; Haloperidol; Humans; Hydrophobic and Hydrophilic Interactions; Imipramine; Metoprolol; Nortriptyline; Potassium Channel Blockers; Promethazine; Propranolol; Quantitative Structure-Activity Relationship; Sotalol; Terfenadine; Verapamil; Xenopus laevis | 2012 |
Excimer formation in inclusion complexes of β-cyclodextrin with salbutamol, sotalol and atenolol: spectral and molecular modeling studies.
Topics: Absorption; Acetonitriles; Albuterol; Atenolol; beta-Cyclodextrins; Electrons; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Nanostructures; Protons; Solvents; Sotalol; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Thermodynamics; Time Factors; Water | 2012 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |
Adsorption and leaching of β-blockers in fluvo-aquic and black soil: Behavior characteristic and enantiomer selectivity.
Topics: Adsorption; Atenolol; Propranolol; Soil; Soil Pollutants; Sotalol | 2022 |
Association of sotalol versus atenolol therapy with survival in dogs with severe subaortic stenosis.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Aortic Stenosis, Subvalvular; Atenolol; Constriction, Pathologic; Dog Diseases; Dogs; Retrospective Studies; Sotalol | 2023 |